Enavatuzumab
   HOME

TheInfoList



OR:

Enavatuzumab is a humanized monoclonal antibody used in the treatment of solid tumors. It targets the TWEAK receptor. Enavatuzumab was developed by Facet Biotech Corp.


References

Monoclonal antibodies {{antineoplastic-drug-stub